DEAMIDIERTES INTERFERON-BETA

European patent · EP1809662 · Deleted

Register entry

Publication number
EP1809662
Application number
EP05818235
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 10, 2005
Published
Jul 25, 2007
Granted
Nov 26, 2008
Deleted
Nov 30, 2014
Reason
Annual fee unpaid
IPC classes
C07K 14/565 (2006.01)
A61K 38/19 (2006.01)
A61P 25/28 (2006.01)
Priority
US 626837 P 10.11.2004
PCT application
PCT/US2005/040758 10.11.2005
PCT publication
WO2006/053134 18.05.2006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 17, 2015

    Deleted, fee unpaid

    Published in Swissreg on 17.06.2015

  2. Feb 24, 2009

    Agent entered

    Representative
    Novartis AG, Lichtstrasse 35, 4056 Basel

    Published in Swissreg on 24.02.2009

  3. Nov 26, 2008

    Granted

    Published in Swissreg on 26.11.2008

Parties

Holder

Novartis Vaccines and Diagnostics, Inc.

4560 Horton Street, Emeryville, CA 94608-2916, US

Agent

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

FURUYA, Kenji

Emeryville, California 94608-2916, US

JOHNSON-JACKSON, Deborah

Emeryville, California 94608-2916, US

RUSCIO, Diana, Tierra

Emeryville, California 94608-2916, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.